This March, Club Parkview is partnering up with WMHF for Men’s Health Month!

 

 

 

Join us on Wednesday 4th March for the Charity Launch Breakfast!

Men across our region experience disproportionate health outcomes, often linked to lower health awareness, delayed care, and a reluctance to seek support early. When men put their health last, the impact extends beyond the individual to families, workplaces, and the wider community

Club Parkview has teamed up with West Moreton Health Foundation to spark conversations and drive action across the region. By tackling men’s health together, your support helps raise awareness, fund research, and invest in equipment that improves care close to home.

 

“West Moreton Health Foundation (WMHF) is the official Foundation supporting West Moreton Health to deliver safe, quality healthcare across Ipswich, Somerset, Scenic Rim and Lockyer Valley communities. With the generous support of individuals, community groups and corporate partners, we raise vital funds through donations, events, appeals and other fundraising initiatives.”

 

On offer will be a

🍴 Plated Breakfast from 7am

☕ Including Tea, Coffee & Juice

🎙 Keynote Speaker – Prof. Jeff Dunn AO

🍀 Lucky Door Prizes & Raffles

🎁 Everyone Receives a Gift!

 

Tickets are

$39.90 for Members

$44.90 for Non-Members

 

We are thrilled to announce Prof. Jeff Dunn AO as our Keynote Speaker!

 

Professor Jeff Dunn AO has an extensive 30-year career in patient-centered care and is among the top 2% of scientists worldwide for oncology!

 

He is the Chief of Mission & Head of Research at the Prostate Cancer Foundation of Australia.
Jeff is also Chair of Cancer Survivorship & Professor of Social and Behavioural Science at UniSQ.
He is a Board Member & Chair of the Audit and Risk Committee for the West Moreton Hospital and Health Service.
Having served on the Board of the Union for International Cancer Control in various capacities over many years, Jeff is the current President-Elect and takes up the Presidency at the World Cancer Congress in October 2022.

 

In 2022, Professor Dunn was diagnosed with a rare form of cancer called Mantle Cell Lymphoma, and although is still undergoing treatment, he continues to champion the needs of cancer survivors.

 

The work that Professor Dunn has not only achieved in Australia, but on an international level, is simply outstanding, and we are eager to hear about his achievements and personal story.